Status
Conditions
Treatments
About
This study evaluates the relative performance of different methods to measure the human spectral contrast sensitivity function (CSF).
Full description
The human spectral contrast sensitivity function (CSF) is a better way to estimate human vision than letter charts commonly used by ophthalmologists, optometrists and opticians.
The current methods used to measure the CSF are often unreliable, due to high variability between measurements. This study will compare four (4) new tests with two (2) currently used standard tests. The contrast sensitivity function will be measured using all of the six (6) methods three times (3) in each of the two (2) eyes at two (2) occasions. Each subjects CSF will be measured 6x3x2x2 = 72 times.
In addition, for each of the CSF measurements, the time used to measure the CSF and number of background variables for the subjects will be recorded.
After informed consent is obtained, the subjects will undergo a visual examination. If they match the inclusion criteria they will be included. At that time or at their earliest possible convenience, their CSF will be measured using the six methods and some background information will be recorded.
The follow-up measurement occasion will occur between 4 to 6 weeks (28 to 42 days) after the first.
To facilitate comparison with previous studies, the CSF-measurements (in rel. contrast/cycles/degree) will be converted to a log (Base 10 logarithm) scale. The unit will thus be log CSF (LCSF) [log[relative contrast]/log[cycles/per degree]].
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 6 patient groups
Loading...
Central trial contact
Lars Malmqvist, M.D; Gunneli Ekberg
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal